Literature DB >> 10592048

Duct changes and K-ras mutations in the disease-free pancreas: analysis of type, age relation and spatial distribution.

J Lüttges1, A Reinecke-Lüthge, B Möllmann, M A Menke, A Clemens, M Klimpfinger, B Sipos, G Klöppel.   

Abstract

Recent molecular studies have suggested that hyperplastic duct lesions of the pancreas are potential precursors of pancreatic ductal carcinoma. This study examines the type, distribution, age-related incidence and K-ras codon 12 mutation rate of duct lesions in the normal pancreas. Postmortem pancreases from 140 patients were screened for the presence of mucinous cell hypertrophy (MHT), ductal papillary hyperplasia (DPH), adenomatoid ductal hyperplasia (ADH), and squamous metaplasia (SQM). Microdissected cell samples were analyzed for K-ras codon 12 mutations by polymerase chain reaction amplification of exon 1 of the K-ras gene, combined with constant denaturing gel electrophoresis, and analyzed by sequencing. Of the 140 specimens 114 showed duct lesions. The lesions were evenly distributed throughout the pancreas. They were more common beyond the age of 40. MHT was present in 68%, DPH in 36%, ADH in 40%, and SQM in 36% of the cases. K-ras mutations were found in 19 samples from 15 out of 79 pancreases (18%), including all types of duct lesions and a variant of ADH with dense stroma. 67% of the K-ras-positive specimens showed the transition GGT to GAT (8) or GTT (5). Hyperplastic/metaplastic duct changes of the pancreas increase with age, but their distribution pattern in the pancreas differs from that of ductal carcinomas.

Entities:  

Mesh:

Year:  1999        PMID: 10592048     DOI: 10.1007/s004280050428

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  30 in total

1.  Frequency of K-ras mutations in pancreatic intraductal neoplasias associated with pancreatic ductal adenocarcinoma and chronic pancreatitis: a meta-analysis.

Authors:  Matthias Löhr; Günter Klöppel; Patrick Maisonneuve; Albert B Lowenfels; Jutta Lüttges
Journal:  Neoplasia       Date:  2005-01       Impact factor: 5.715

Review 2.  Kras and Tumor Immunity: Friend or Foe?

Authors:  Jane Cullis; Shipra Das; Dafna Bar-Sagi
Journal:  Cold Spring Harb Perspect Med       Date:  2018-09-04       Impact factor: 6.915

Review 3.  Genomic profiling guides the choice of molecular targeted therapy of pancreatic cancer.

Authors:  Thomas S Frank; Xiaotian Sun; Yuqing Zhang; Jingxuan Yang; William E Fisher; Marie-Claude Gingras; Min Li
Journal:  Cancer Lett       Date:  2015-04-15       Impact factor: 8.679

4.  EGF receptor is required for KRAS-induced pancreatic tumorigenesis.

Authors:  Christine M Ardito; Barbara M Grüner; Kenneth K Takeuchi; Clara Lubeseder-Martellato; Nicole Teichmann; Pawel K Mazur; Kathleen E Delgiorno; Eileen S Carpenter; Christopher J Halbrook; Jason C Hall; Debjani Pal; Thomas Briel; Alexander Herner; Marija Trajkovic-Arsic; Bence Sipos; Geou-Yarh Liou; Peter Storz; Nicole R Murray; David W Threadgill; Maria Sibilia; M Kay Washington; Carole L Wilson; Roland M Schmid; Elaine W Raines; Howard C Crawford; Jens T Siveke
Journal:  Cancer Cell       Date:  2012-09-11       Impact factor: 31.743

5.  Cigarette smoking accelerates progression of alcoholic chronic pancreatitis.

Authors:  P Maisonneuve; A B Lowenfels; B Müllhaupt; G Cavallini; P G Lankisch; J R Andersen; E P Dimagno; A Andrén-Sandberg; L Domellöf; L Frulloni; R W Ammann
Journal:  Gut       Date:  2005-04       Impact factor: 23.059

6.  Autoimmune pancreatitis misdiagnosed as a tumor of the head of the pancreas.

Authors:  Eran Brauner; Jesse Lachter; Offir Ben-Ishay; Euvgeni Vlodavsky; Yoram Kluger
Journal:  World J Gastrointest Surg       Date:  2012-07-27

Review 7.  Evolution of pancreas in aging: degenerative variation or early changes of disease?

Authors:  Tanyaporn Chantarojanasiri; Yoshiki Hirooka; Thawee Ratanachu-Ek; Hiroki Kawashima; Eizaburo Ohno; Hidemi Goto
Journal:  J Med Ultrason (2001)       Date:  2014-09-13       Impact factor: 1.314

Review 8.  The pathology of ductal-type pancreatic carcinomas and pancreatic intraepithelial neoplasia: insights for clinicians.

Authors:  Günter Klöppel; Jutta Lüttges
Journal:  Curr Gastroenterol Rep       Date:  2004-04

Review 9.  Mechanisms of resistance to EGFR targeted therapies.

Authors:  Gorjan Hrustanovic; Bianca J Lee; Trever G Bivona
Journal:  Cancer Biol Ther       Date:  2013-01-28       Impact factor: 4.742

Review 10.  Pancreatic ductal adenocarcinoma: risk factors, screening, and early detection.

Authors:  Andrew E Becker; Yasmin G Hernandez; Harold Frucht; Aimee L Lucas
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.